Why the study?
Does Prostaglandin E1 inhibit platelet aggregation and haemostasis in pig and rabbit models?
Does Prostaglandin E1 inhibit platelet aggregation and haemostasis in pig and rabbit models?
Prostaglandin E1 inhibits platelet aggregation and haemostasis by preventing ADP release and ADP-induced aggregation in preclinical models.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for PGE1 antiplatelet effects; human trials needed before clinical consideration.
S ummary Low concentrations of prostaglandin E 1 (PGE 1 ) inhibit ADP‐induced aggregation in pig and rabbit citrated platelet‐rich plasma and in suspensions of washed platelets. Higher concentrations also inhibit the initial change in shape induced by ADP and the release of platelet ATP, ADP and serotonin caused by stimuli such as collagen, thrombin, antigen‐antibody complexes and gamma‐globulin‐coated polystyrene particles. PGE 1 is not taken up by platelets and its effects can be removed by resuspending platelets in fresh medium. Immediately following an intra‐arterial injection, ADP‐induced platelet aggregation is suppressed, but after 5 min the response returns to normal. PGE 1 inhibits haemostasis in rabbits when given as a continuous infusion. It is concluded that the effect of PGE 1 on haemostasis involves inhibition of the release of ADP from platelets exposed to collagen and thrombin, and inhibition of ADP‐induced aggregation.
No takes yet. Share an insight, caveat, or question.
Kinlough-Rathbone et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: